EU4Health Calls – open for applications

Next-Generation Influenza Vaccines, AST PoC Medical Device (AMR), & Mpox Vaccine Clinical Trial

Please note that all three procedures are now open for proposals.

💉 Multiple Sourcing Framework Contracts to Speed up the Development of and Access to Innovative Medical Countermeasures: Next-Generation Influenza Vaccines 💉

Scope: This call for tenders seeks to accelerate the development of next-generation, rapidly scalable influenza vaccines with innovative production platforms, novel administration routes, broad protection against pandemic influenza A viruses, and intrinsic immunogenicity, through a phased Pre-Commercial Procurement process. This is a competitive procedure with negotiation with a maximum contract duration of 98 months.

⏰ 19/05/2025 15:00 Europe/Brussels
💶 EUR 225Mio (per service contract established = phase 1 – EUR 12.95Mio, Phase II – EUR 35Mio (estimate), and Phase III – EUR 100Mio (estimate) – see ‘tender specifications’ document)
🔗 Next-generation Influenza Vaccine F&Ts Application Webpage

🔬 Development of a rapid point-of-care antimicrobial susceptibility testing diagnostic medical device 🔬

Scope: This call for tenders seeks to accelerate the development of rapid point-of-care diagnostic devices providing antimicrobial susceptibility results within one hour, ideally with pathogen identification, targeting priority bacterial and fungal pathogens, progressing from TRL 3+ towards CE marking and TRL 8 qualification. This is a competitive procedure with negotiation with a maximum contract duration of 48 months.

⏰ 12/05/2025 16:00 Europe/Brussels
💶 EUR 12.86Mio
🔗 PoC AMR/AST Diagnostic Device F&Ts Application Webpage

🦠 Speed up the access to and uptake of an Mpox vaccine 🦠

Scope: This call for tenders aims to generate scientific evidence on the immune response to the MVA-BN vaccine, focusing on the need and optimal timing of booster doses through Phase II and/or III clinical trials, comparing intradermal and subcutaneous administration, to inform public health strategies, EU policies, and stockpiling initiatives. This is an open procedure with a maximum contract duration of 36 months.

⏰ 21/04/2025 16:00 Europe/Brussels
💶 EUR 4.9Mio
🔗 Mpox Vaccine Study F&Ts Application Webpage